ROSEMARY BIGGS and R. G. MACFARLANE strong suspensions of brain extract thrombin is formed in the same amount and at the same speed in haemophilic as in normal plasma or from haemophilic prothrombin and Factor V as compared with normal factors (Biggs, 1951b) . Quick (1947) has claimed that haemophilic plasma reacts normally to even minute amounts of thromboplastin, but other workers would not agree with this statement. Addis, in 1911 , showed that haemophilic plasma clotted more slowly than normal with added testis or kidney thromboplastin, and more recent observations suggest that its reaction to weak brain suspensions is less rapid than normal (Pavlovsky, Mittelman, and Castellanos, 1949; Dreskin and Rosenthal, 1950; Frommeyer, Epstein, and Taylor, 1950) .
In view of this uncertainty it was considered that a study of the reactions of normal and haemophilic plasma and plasma fractions with different concentrations of thromboplastic agents might provide further information on the mode of action of the " antihaemophilic factor." Technique Reagents.-The following reagents were used: Brain Thronmboplastin.-Fresh human brain is collected in the post-mortem room, and all superficial vessels and meninges are removed. The substance is macerated with three or four times its volume of acetone in a mortar. The acetone is replaced four times, and the granular powder is dried by means of a suction filter. The dried brain can be stored for periods up to three months at room temperature with no special precautions.
For use 0.5 g. of the granular powder is suspended in 5 ml. of saline and incubated at 370 C. for 15 minutes. The suspension is mixed once or twice during this time, and the coarse particles are allowed to settle by gravity. The supernatant fluid is removed and diluted 1/5 with 0.85% saline.
Calcium Chloride.-An M/40 solution of anhydrous calcium chloride is used. Fibrinogen (Jaques, 1943 ).-First a 3 M phosphate buffer at pH 6.6 is made by dissolving 817 g. of anhydrous KH2PO4 in 1,000 ml. of distilled water. To this is added 750 ml. of 4N KOH. After warming, the volume is made up to 2,000 ml. and the solution is filtered.
Secondly, a preparation of Al(OH)3 suspension (Bertho and Grassmann, 1938) is made up as follows: 100 ml. of 10% ammonia solution is poured into 600 ml. of water at 630 C. containing 22 g. of ammonium sulphate, and the temperature is rapidly brought to 580 C. The mixture is stirred vigorously and poured, in one lot, into a solution of 76.7 g.
of ammonium alum at a temperature of 580 C. The temperature rises to 610 C.
Stirring is continued for 10 minutes, during which time the temperature is maintained above 58°C. The precipitate is separated by centrifuging. The precipitate is washed five times with 1,500 ml. of distilled water, sepa.rating the precipitate by centrifuging on each occasion. To the first washing water is added 0.44 ml. of 10% ammonia, and to the second 0.88 ml. of 10% ammonia. The whole procedure does not take much more than two hours. The precipitate is suspended in the least amount of distilled water that is required to make a solution that can be pipetted.
Thirdly, the fibrinogen is prepared. To 100 ml. of citrated plasma obtained from "bank" blood is added 2 ml. of Al(OH)3 suspension to remove the prothrombin. The Al(OH)3 is removed by centrifuging and discarded. To 100 ml. of this prothrombin-free plasma is added 100 ml. of 2 M phosphate buffer at pH 6.6 Fibrinogen Fraction (Fraction 1).-Plasma, 10 ml., was largely freed from platelets by centrifuging for half an hour at 3,000 r.p.m. To the clear plasma were added 2 g. of solid ammonium sulphate. The mixture was well shaken to ensure the complete solution of the ammonium sulphate and the precipitate removed by centrifuging. The precipitate was dissolved in 5 ml. of 0.85% saline and dialysed overnight against saline containing 1/10 of its volume of 3.8% sodium citrate.
Globulin Fraction (Fraction II).-A further 1 g. of solid ammonium sulphate was added to the supernatant from the preparation of Fraction I. The precipitate was collected by centrifuging and dissolved in 5 ml. of 0.85% saline and dialysed against citrate saline.
Albumin Fraction (Fraction III).-The supernatant from the preparation of Fraction II was dialysed against citrate saline.
Technical Methods
One-stage Prothrombm Time.-Plasma, 0.1 ml., is mixed with 0.1 ml. of thromboplastin, and the mixture warmed to 370 C.; 0.1 ml. of M/40 calcium chloride is then added and the coagulation time recorded. Two-stage Prothrombin Test.-A modification of the method of Herbert (1940) and Owren (1947) was used. Plasma, 0.3 ml., and 0.3 ml. of saline were mixed with 0.3 ml. of brain emulsion, and the mixture was warmed to 370 C. Then 0.3 ml. of M /40 calcium chloride was added, and at various intervals from one to 30 minutes 0.1 ml. samples were removed and added to 0.4 ml. amounts of fibrinogen in small tubes previously prepared and placed in the water bath. The coagulation times of the fibrinogen were recorded. The concentration of fibrinogen was adjusted to approximately 100 mg. %. If thrombin formation was followed in the globulin fraction instead of whole plasma, 0.3 ml. of globulin fraction was mixed with 0.3 ml. saline or 0.3 ml. of the " albumin fraction" and 0.3 ml. of brain emulsion. Then 0.3 ml. of M /40 CaCl2 was added, and thrombin generation was followed as before.
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Experimental Results
Experiments on Whole Plasma.-A few experiments were made using the onestage method. Using normal and haemophilic plasma samples, the one-stage method was carried out with dilutions of brain emulsion varying from 1/10 to 1/50,000. The clotting time obtained with each sample of haemophilic plasma was then plotted against the clotting time of the corresponding normal plasma obtained with the same thromboplastin preparation. From Fig. 1 it will be seen that when the thromboplastin preparation was diluted to give with normal plasma a clotting time of more than 40 seconds, usually the haemophilic plasma had a longer clotting time than the normal. Thus, with quite strong suspensions of thromboplastin, the reaction of haemophilic plasma was abnormal.
This abnormality might be attributed to an initial deficiency of thromboplastin in the haemophilic plasma due to its supposed inability to generate intrinsic thromboplastin activity. If this is the true explanation, then an appropriate addition of thromboplastin to the haemophilic plasma should correct the defect. Enough thromboplastin was added to haemophilic plasma to make its clotting time the same as that of the normal plasma to which no thromboplastin had been added. The amount required was a 1/10,000 concentration of brain emulsion. Further additions of thromboplastin were then made to both normal and haemophilic plasma. From Fig. 2 it will be seen that the further additions of thromboplastin had less effect on haemophilic than on normal plasma. The defect in haemophilic plasma therefore cannot be attributed to a simple deficiency in thromboplastin.
The long clotting time of haemophilic plasma might be due to its neutralization of thromboplastin. A number of samples of normal and haemophilic plasma were incubated with brain thromboplastin for one hour, and at intervals samples were recalcified. The clotting time of both normal and haemophilic samples lengthened slightly, but there was no striking difference in their behaviour on incubation, though the clotting times of the haemophilic plasma samples were consistently longer than those of the normal (Fig. 3) . In a further experiment one normal and two samples of haemophilic plasma were incubated at 370 C. for one hour with two strengths of brain thromboplastin. At the end of this time the samples were used undiluted and diluted 1/10 as a source of thromboplastin for the one-stage method. The samples were tested on the same normal and the same two samples of haemophilic blood in all combinations. The results of this experiment are set out in Tables I and II Three plasma samples, one normal and two haemophilic, were incubated at 37°C. for one hour with an equal volume of brain emulsion diluted IIS and 1/50 with 0-85% saline. At the end of the hour these samples were diluted I/ 10 with 0 85% saline, giving final dilutions of brain emulsion of 1/50 and 1/500 and used as a source of thromboplastin.
It is possible that haemophilic plasma contains an inhibitor of thromboplastic action which requires the presence of calcium or which is inhibited by sodium citrate. This possibility was not investigated, because it is difficult to study the destruction of thromboplastin in a system which is forming thrombin and a serum accelerator of thrombin formation.
In the majority of experiments thrombin formation was followed by the twostage method in a system containing the albumin fraction which has a potent antithrombic action. Thrombin was therefore destroyed progressively as it was formed, and it is important to appreciate the factors which influence the concentration of thrombin in a system of this sort. The amount of thrombin available depends on the relative speeds of its formation and destruction.
The effect of varying the speed of formation may be shown in an experiment in which the amount of thromboplastin added to plasma in the two-stage method is varied. The stronger suspensions of thromboplastin lead to rapid thrombin generation, and a high level of thrombin is detected. With slow speeds of generation much less thrombin can be demonstrated (Fig. 4) , although the same total amount is probably produced. 
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The speed of production may be kept constant and the activity of the antithrombin may be increased by adding to a saline dilution of plasma plasma adsorbed with Al(OH)3 to remove prothrombin. When plasma prepared in this way is tested by the two-stage method the curves in Fig. 5 result. Similar curves result from the addition of heparin to plasma. The amount of thrombin detected is controlled both by the speed of thrombin formation and the speed of its destruction.
In a number of samples of haemophilic plasma thrombin formation was studied by the two-stage method, using a 1/100 or 1/1,000 dilution of brain thromboplastin. In Fig. 6 the results in three individual haemophilic plasmas are compared with the average for four normal plasmas. From the previous discussion it is probable that the difference between the haemophilic and normal plasmas lies mainly in a difference in the speed of thrombin formation.
The addition of normal plasma to haemophilic whole plasma greatly improves the reaction of haemophilic plasma to weak suspensions of brain thromboplastin. In Fig. 7 are shown the effects on thrombin formation of adding 1/10 and 1/2 proportion of normal plasma to haemophilic plasma. These results are the mean values for eight experiments on the blood of different haemophilic and normal people. It will be seen that 1/10 volume of normal plasma considerably increases the speed of thrombin formation, but that even 50% of normal plasma does not restore thrombin formation to normal. The effect of 1/10 dilution of normal plasma is worth emphasizing. In previous experiments it was found that a concentration of 1/10,000 brain emulsion was required to bring the one-stage clotting time of haemophilic plasma to the same as that of normal plasma. Therefore, if the defect in haemophilic plasma is due to a deficiency in thromboplastin, normal plasma must contain an excess of thromboplastin in comparison with haemophilic plasma, and this excess is approximately equal to a brain concentration of 1 /10,000. The addition of 1/10 proportion of normal to haemophilic plasma would therefore be equivalent to the addition of 1/100,000 dilution of brain thromboplastin. This concentration of brain thromboplastin is practically inactive with haemophilic plasma. This experiment therefore confirms the view that the defect in haemophilia cannot be a simple lack of thromboplastin.
Experiments on Plasma Fractions.-It has been shown previously (Biggs, 1951b ) that prothrombin and Factor V isolated from haemophilic plasma have a normal reaction to platelet thromboplastin. It is therefore probable that the abnormal reaction of whole haemophilic plasma to thromboplastin is a feature of whole plasma, which is lost on fractionation. An attempt to identify the cause of the abnormality was made by a more simple fractionation of the plasma. Whole normal plasma and whole haemophilic plasma were dialysed against distilled water, and the globulin fraction precipitated by bringing the pH to 5. This fraction was dissolved in saline and neutralized. The supernatant plasma was neutralized and called the albumin fraction. In fact, this fraction was a crude mixture of albumin and globulin. These fractions were tested in various mixtures by the two-stage method, using a weak suspension of brain thromboplastin. The experiment was carried out on five haemophilic and five normal subjects.
The formation of thrombin in the globulin fraction alone given as an average for the five experiments shows no difference between the normal and haemophilic fractions (Fig. 8) . This results suggests that the factor causing the abnormal reaction The fact that the so-called globulin fractions from normal and haemophilic plasma behaved in the same manner, and the fact that the speed of thrombin was accelerated if both the antihaemophilic factor and the albumin fraction were present, suggest that the full effectiveness of the antihaemophilic factor depends in some way on its interaction with some substance in the albumin fraction.
An attempt was made to obtain a more specific separation of important components by ammonium sulphate fractionation. In this way fractions precipitated at 33% and 50% saturation with ammonium sulphate and a supernatant from the 50% saturation were isolated. The 33% fraction (Fraction I, or fibrinogen fraction) from normal plasma contained the fibrinogen and antihaemophilic factor, Fraction I from the haemophilic plasma contained no antihaemophilic factor, the 50% fraction (Fraction II, or globulin fraction) contained prothrombin and Factor V, and the supernatant from the 50% fraction (Fraction III, or albumin fraction) contained antithrombin. The only fraction which showed any ability to shorten the clotting time in haemophilic plasma was the 33 % fraction from normal plasma. These fractions were tested for their ability to form thrombin, and in general the results confirm the findings obtained with the acid fractionation. Some of the experiments are illustrated in Figs. 11 and 12.
When tested alone Fractions I and II from normal and haemophilic plasma behaved similarly. In Fig. 11 the three normal fractions were tested together and gave a rapid speed of thrombin generation. When the normal Fraction I was replaced by that from haemophilic blood there was a considerable delay in thrombin formation. When in addition the haemophilic albumin fraction replaced the normal albumin fraction a further reduction in the speed of thrombin formation occurred.
In Fig. 12 similar experiments with the haemophilic fractions are shown. When all three fractions from haemophilic plasma were used thrombin formation was poor. When the haemophilic Fraction I was replaced by that from normal plasma the speed of thrombin formation was accelerated. The further replacement of the haemophilic albumin fraction by the corresponding normal fraction led to a second increase in the speed of thrombin formation.
The fact that the globulin fractions from haemophilic and normal plasma behaved similarly, and that the normal albumin fraction accelerated the speed of thrombin formation from the normal globulin fraction, suggests that the full effectiveness of the antihaemophilic factor depends on its co-operation with a factor in the albumin fraction.
The inhibitory effect of the haemophilic albumin fraction in this experiment may have been due to the presence of an inhibitory substance as a result of immunization following repeated transfusions (Frommeyer et al., 1950) 
